Monthly Archives: May 2012

Fed. Cir. Orders Briefing in Myriad Remand

On April 30th, in response to the Supreme Court’s GVR of the Myriad appeal (AMP et al. are still trying to get the claims to isolated DNA molecules and the use of a transgenic cell comprising the BRCA1 gene to … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , | 1 Comment